Potassium Citrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09125 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 87 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | familial visceral myopathy | KG + DL |
| 2 | mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | KG + DL |
| 3 | Pendred syndrome | KG + DL |
| 4 | nephrolithiasis | KG + DL |
| 5 | cystinosis | KG + DL |
| 6 | hypermanganesemia with dystonia | KG + DL |
| 7 | nephrolithiasis susceptibility caused by SLC26A1 | KG + DL |
| 8 | autosomal recessive nonsyndromic deafness | KG + DL |
| 9 | exocrine pancreatic insufficiency | KG + DL |
| 10 | leukocyte adhesion deficiency | KG + DL |
| 11 | NAD(P)HX dehydratase deficiency | KG + DL |
| 12 | adult Fanconi syndrome | KG + DL |
| 13 | Fraser syndrome | KG + DL |
| 14 | Alstrom syndrome | KG + DL |
| 15 | temtamy preaxial brachydactyly syndrome | KG + DL |
| 16 | human HOXA1 syndromes | KG + DL |
| 17 | dyspepsia | KG + DL |
| 18 | glycogen storage disease due to GLUT2 deficiency | KG + DL |
| 19 | myopathic intestinal pseudoobstruction | KG + DL |
| 20 | unclassified intestinal pseudoobstruction | KG + DL |
| 21 | neuronal intestinal dysplasia, type B | KG + DL |
| 22 | exercise-induced malignant hyperthermia | KG + DL |
| 23 | primary Fanconi syndrome | KG + DL |
| 24 | intestinal obstruction | KG + DL |
| 25 | congenital short bowel syndrome 1 | KG + DL |
| 26 | osteopetrosis | KG + DL |
| 27 | HELIX syndrome | KG + DL |
| 28 | combined oxidative phosphorylation defect | KG + DL |
| 29 | deafness dystonia syndrome | KG + DL |
| 30 | malignant hyperthermia, susceptibility to | KG + DL |
| 31 | calcium-alkali syndrome | KG + DL |
| 32 | King-Denborough syndrome | KG + DL |
| 33 | urolithiasis | KG + DL |
| 34 | intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked | KG + DL |
| 35 | primary bone dysplasia | KG + DL |
| 36 | obsolete CFM1 | KG + DL |
| 37 | central core myopathy | KG + DL |
| 38 | neuronal intestinal pseudoobstruction | KG + DL |
| 39 | renal hypomagnesemia | KG + DL |
| 40 | congenital multicore myopathy with external ophthalmoplegia | KG + DL |
| 41 | moderate multiminicore disease with hand involvement | KG + DL |
| 42 | primary bone dysplasia with defective bone mineralization | KG + DL |
| 43 | immune-mediated necrotizing myopathy | KG + DL |
| 44 | antisynthetase syndrome | KG + DL |
| 45 | cytochrome-c oxidase deficiency disease | KG + DL |
| 46 | inflammatory myopathy with abundant macrophages | KG + DL |
| 47 | idiopathic eosinophilic myositis | KG + DL |
| 48 | X-linked centronuclear myopathy | KG + DL |
| 49 | focal myositis | KG + DL |
| 50 | Jervell and Lange-Nielsen syndrome | KG + DL |
(Showing top 50 of 87 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.